7 February 2016

Bango

(BGO)

Company Details

Address:
5 Westbrook Centre , Cambridge CB4 1YG
Telephone:
01223 472 777
Fax:
01223 472 778
Email:
Ray@bango.com
Website:
www.bango.com

Commentary

Mobile web payments and analytics company

Executives

Non-Exec Chairman:
David Sear (0.0% holding)
Chief Executive:
Ray Anderson (10.3% holding)
CFO:
Gerry Tucker (0.0% holding)
Chief Mktg Officer:
Anil Malhotra (6.2% holding)

Main Shareholders

Liontrust Investment Partners: 17.2%

Herald Investment Management: 14.4%

Odey Asset Management: 11.0%

Schroders: 5.3%

Inflection Point Investments: 5.1%

Advisers

Nominated Adviser:
Cenkos Securities
Nominated Broker:
Cenkos Securities
Solicitors:
Taylor Wessing
Auditors:
Grant Thornton
Registrar:
Computershare Investor Services

Accounts Information

Entry on AIM:
30/6/2005
Issue Price:
134.0p
Interim Results:
Sep
Final Results:
Mar
Year End:
Dec
Accounts Due:
Mar
Int div payment:
n/a
Fin div payment:
n/a
Int net div per share:
nil
Fin net div per share:
nil

Financial History

  2014 2013
Turnover: £5.09m £8.79m
Pre-tax profit: £ (5.41m) £ (4.93m)
EPS: (10.96) p (10.53) p

Associated Articles

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

The role of a nominated adviser

Dr Azhic Basirov, Head of Capital Markets at Smith & Williamson Corporate Finance explains what to look for in a nominated adviser, along with the nomad’s role, fees and the key questions you should ask. Read this feature on the role of a nominated adviser.

What Investment magazine: save 45% on the shop price

Be the first to receive our independent analysis and research, designed to help you generate more wealth for you and your family over the long term. Subscribe and save.

Popular News

Latest News

Forbidden focuses on selling

Forbidden Technologies (AIM: FBT) has been around a long time but has failed to generate much in the way of revenues, despite having a product that sounds like it should be a winner. There were board changes last year and new CEO Aziz Musa is shifting resources towards selling and away from technological development. This has to be the right strategy and we should find out if it’s working as this year unfolds.

Wash those nits right out of your hair!

Tyratech (AIM: TYRU) offers a compelling product proposition. Controlling bugs and parasites using conventional pesticides is both harmful to the environment and ineffective. Over the years insects have built up resistance to many of the chemicals used to kill them. So Tyratech’s natural products are not only safer but also a lot more effective than the competition. 

Angling for a cancer breakthrough

Results from medical device manufacturer Angle (AIM: AGL) showed its innovative Parsortix system to be nicely on track. The first commercial sales for research use have just been made and three leading cancer centres are moving forward with trials that will support its clinical use in the diagnosis of ovarian cancer.

2016 Quoted Company Award Winners announced

The 12th annual Grant Thornton Quoted Company Awards took place this week at the Natural History Museum in London. This prestigious event is organised by Growth Company Investor and is a celebration of the success and achievements of the UK’s smaller company sector. We published the shortlisted nominees for each award category earlier in January; so read on to see who the winners were...

Plexus hammered by oil industry shutdown

In the middle of 2014 Plexus (AIM: POS) was riding high with a share price of 320p giving the company a market value of £270 million. Today’s profit warning has seen the shares slump 40 per cent to just 73p, valuing Plexus at a mere £65 million. As an engineering company selling mainly into the oil industry, we shouldn’t be too surprised by downgrades. But the severity is startling.

Fusionex shares plunge on hidden profit warning

Malaysian big data software specialist Fusionex (AIM: FXI) has released an upbeat results statement for the year to September. As well as beating historic forecasts, the new financial year is said to have started “on a very strong note… the outlook for 2016 and beyond is very positive”. Sounds fantastic! Yet by this afternoon the shares had collapsed by 35 per cent.

More News